FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PN6SSK5

Delayed Deutsche Boerse AG 06:21:06 2024-06-20 am EDT
0.53 EUR +8.16% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-23.44%
1 month-30.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 0.53 +8.16%
24-06-19 0.49 -10.91%
24-06-18 0.55 -6.78%
24-06-17 0.59 0.00%
24-06-14 0.59 -1.67%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 06:21 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN6SSK
ISINDE000PN6SSK5
Date issued 2022-09-30
Strike 344.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 103.9
Lowest since issue 0.45
Spread 0.03
Spread %5.36%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus